CAPTRUST Financial Advisors
ISEE

CAPTRUST Financial Advisors’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

CAPTRUST Financial Advisors’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-49,789
Closed -$1.96M – 2768
2023
Q2 		$1.96M Buy
49,789
+41,166
+477% +$1.45M 0.01% 832
2023
Q1 		$210K Buy
+8,623
New +$189K ﹤0.01% 2024
2022
Q3 		– Sell
-1,663
Closed -$16K – 4431
2022
Q2 		$16K Buy
1,663
+163
+11% +$2.05K ﹤0.01% 3507
2022
Q1 		$25K Buy
1,500
+1,490
+14,900% +$22K ﹤0.01% 3266
2021
Q4 		$0 Buy
+10
New +$164 ﹤0.01% 4997

CAPTRUST Financial Advisors's ISEE Position: Q3 2023 in Review

CAPTRUST Financial Advisors sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 49,789 shares — an estimated $1.96M sold.

CAPTRUST Financial Advisors first reported a position in ISEE in Q4 2021 and held it in 5 quarters. The position peaked at $1.96M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

  • CAPTRUST Financial Advisors reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 49,789 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $1.96M.
  • CAPTRUST Financial Advisors first reported a position in IVERIC bio, Inc. Common Stock in Q4 2021 and held it in 5 quarters.
  • CAPTRUST Financial Advisors's IVERIC bio, Inc. Common Stock position peaked at $1.96M in Q2 2023.
  • 0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on CAPTRUST Financial Advisors's 13F filing for Q3 2023, filed 15 Nov 2023.